4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0002081359-26-000002
Chief Science Officer sold 3,873 shares at $16.35 ($63,324)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lerner Lorena Raquel Chief Science Officer | 2026-02-18 | Sale | −3,873 | $16.35 | $63,324 | 31,127 | D: show line 1 in the form |
| Open-market sales · 3,873 sh · avg $16.35 · $63,324 | |||||||
Loading xslF345X05/form4-02202026_040205.xml…